NASDAQ$ZIMV
ZimVie Inc · Q3 2022 earnings
Q3 2022 earnings · · Investor relations
Briefing
ZimVie's Q3 2022 financial performance was reported, with progress in dental and spine portfolios.
ZimVie reported third-party net sales of $213.3 million. Net income was $0.8 million, with a diluted EPS of $0.03. Adjusted EBITDA was $29.4 million. The company reaffirmed its full-year 2022 guidance for third-party net sales and adjusted EPS.
- Third party net sales of $213.3 million
- Net income of $0.8 million; net income margin of 0.4%
- Diluted EPS of $0.03
- Cash and cash equivalents of $116.0 million at September 30, 2022
Headline financials
Revenue & EPS history
ZimVie · Revenue · Quarterly
$215M
Forward guidance
ZimVie reaffirmed guidance for third party net sales of $915 to $930 million, with expectations for the dental business to deliver mid single digit growth in constant currency and the spine business to decline in the low double digits in constant currency. They are reaffirming adjusted EBITDA margin guidance of flat to 50bps improvement from prior year margin of 13.1%. They are reaffirming adjusted EPS guidance of $1.80 to $2.00.
Tailwinds
- Dental business expected to deliver mid single digit growth in constant currency
- Reaffirming adjusted EBITDA margin guidance of flat to 50bps improvement from prior year margin of 13.1%.
- Reaffirming adjusted EPS guidance of $1.80 to $2.00.
Headwinds
- Spine business to decline in the low double digits in constant currency
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 6 quarterly earnings reports
-1.7%
Avg return
Earnings day
-3.4%
Avg return
5 days after
-5.3%
Avg return
30 days after
44%
8 / 18 earnings
Positive
+24.0%
Q1 2023
Best reaction
-49.0%
Q4 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2025 | — | — | — | |
| Q2 2025 | -0.4% | -0.1% | +0.1% | |
| Q1 2025 | -4.4% | -4.8% | +2.2% | |
| Q4 2024 | -1.7% | +3.1% | -11.9% | |
| Q3 2024 | +0.6% | +5.5% | +6.2% | |
| Q2 2024 | -18.2% | -19.0% | -17.9% | |
| Q1 2024 | +5.7% | +4.8% | +0.8% | |
| Q4 2023 | -14.4% | -13.4% | -16.9% | |
| Q3 2023 | +5.4% | — | — | |
| Q2 2023 | -6.0% | — | — | |
| Q1 2023 | +24.0% | — | — | |
| Q4 2022 | -49.0% | — | — | |
| Q3 2021 | +20.0% | — | — | |
| Q3 2022 | +20.0% | — | — | |
| Q2 2021 | -8.2% | — | — | |
| Q2 2022 | -8.2% | — | — | |
| Q1 2021 | -6.5% | — | — | |
| Q4 2021 | +5.1% | — | — | |
| Q4 2020 | +5.1% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro